Using a simple equation to predict the microporation-enhanced transdermal drug flux

Harding, 2004, The stratum corneum: structure and function in health and disease, Dermatol. Ther., 17, 6, 10.1111/j.1396-0296.2004.04S1001.x Jepps, 2013, Modeling the human skin barrier – towards a better understanding of dermal absorption, Adv. Drug. Deliv. Rev., 65, 152, 10.1016/j.addr.2012.04.003 Ita, 2014, Transdermal drug delivery: progress and challenges, J. Drug Del. Sci. Technol., 24, 245, 10.1016/S1773-2247(14)50041-X Wiedersberg, 2014, Transdermal drug delivery: 30+ years of war and still fighting!, J. Control. Release, 190, 150, 10.1016/j.jconrel.2014.05.022 Prausnitz, 2008, Transdermal drug delivery, Nat. Biotechnol., 26, 1261, 10.1038/nbt.1504 T.R.R. Singh, R.F. Donnelly, Microporation in penetration enhancement. In: Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement, Springer, 2017, pp. 257–271. Banga, 2009, Microporation applications for enhancing drug delivery, Expert Opinion Drug Del., 6, 343, 10.1517/17425240902841935 Kalluri, 2011, Formation and closure of microchannels in skin following microporation, Pharm. Rese., 28, 82, 10.1007/s11095-010-0122-x Donnelly, 2010, Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety, Drug. Deliv., 17, 187, 10.3109/10717541003667798 Rzhevskiy, 2016, Modelling drug flux through microporated skin, J. Control. Release, 241, 194, 10.1016/j.jconrel.2016.09.029 Anissimov, 2011, Modelling dermal drug distribution after topical application in human, Pharm. Res., 28, 2119, 10.1007/s11095-011-0437-2 Leite-Silva, 2016, Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment, Eur. J. Pharm. Biopharm., 104, 140, 10.1016/j.ejpb.2016.04.022 Y. Bachhav, S. Summer, A. Heinrich, T. Bragagna, C. Böhler, Y. Kalia, PLEASE® A promising tool for intraepidermal drug delivery, in: Annual Meeting of the Controlled Release Society, 2008. Bachhav, 2010, Effect of controlled laser microporation on drug transport kinetics into and across the skin, J. Control. Release, 146, 31, 10.1016/j.jconrel.2010.05.025 Bachhav, 2011, Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications, Eur. J. Pharm. Biopharm., 78, 408, 10.1016/j.ejpb.2011.03.006 Bachhav, 2013, Controlled intra-and transdermal protein delivery using a minimally invasive Erbium: YAG fractional laser ablation technology, Eur. J. Pharm. Biopharm., 84, 355, 10.1016/j.ejpb.2012.11.018 Magnusson, 2004, Molecular size as the main determinant of solute maximum flux across the skin, J. Invest. Dermatol., 122, 993, 10.1111/j.0022-202X.2004.22413.x Ranganathan, 2003, Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?, Ann. Rheum. Dis., 62, 4, 10.1136/ard.62.1.4 Taudorf, 2015, Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation, Expert Opin. Drug Deliv., 12, 1059, 10.1517/17425247.2015.1031216